PI
SRPT icon

PEAK6 Investments’s Sarepta Therapeutics SRPT Stock Holding History

PEAK6 Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.58M Sell
44,700
-10,500
-19% -$1.45M 0.01% 874
2024
Q2 		$8.72M Buy
55,200
+25,500
+86% +$3.28M 0.02% 546
2024
Q1 		$3.84M Hold
29,700
– – 0.01% 986
2023
Q4 		$2.86M Sell
29,700
-2,100
-7% -$201K 0.01% 1228
2023
Q3 		$3.85M Buy
31,800
+29,700
+1,414% +$3.36M 0.02% 897
2023
Q2 		$240K Sell
2,100
-25,000
-92% -$3.22M ﹤0.01% 2763
2023
Q1 		$3.74M Sell
27,100
-194,800
-88% -$25.3M 0.02% 869
2022
Q4 		$28.8M Buy
221,900
+52,500
+31% +$6.08M 0.17% 101
2022
Q3 		$18.7M Buy
169,400
+66,700
+65% +$6.72M 0.08% 233
2022
Q2 		$7.78M Buy
+102,700
New +$7.56M 0.01% 1033
2020
Q4 		– Sell
-8,300
Closed -$1.17M – 5122
2020
Q3 		$1.17M Sell
8,300
-11,700
-59% -$1.78M ﹤0.01% 2134
2020
Q2 		$3.21M Buy
+20,000
New +$2.72M 0.01% 1114
2020
Q1 		– Sell
-4,000
Closed -$516K – 4517
2019
Q4 		$516K Hold
4,000
– – ﹤0.01% 1951
2019
Q3 		$301K Sell
4,000
-20,400
-84% -$2.41M ﹤0.01% 2639
2019
Q2 		$3.71M Buy
+24,400
New +$2.97M 0.02% 876
2019
Q1 		– Sell
-80,800
Closed -$8.82M – 4580
2018
Q4 		$8.82M Buy
80,800
+40,400
+100% +$5.05M 0.06% 380
2018
Q3 		$6.53M Buy
+40,400
New +$5.52M 0.03% 652

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PEAK6 Investments's SRPT Position: Q3 2023 in Review

PEAK6 Investments sold out of Sarepta Therapeutics (SRPT) in Q3 2023, closing a stake of 5,094 shares — an estimated $576K sold.

PEAK6 Investments first reported a position in SRPT in Q1 2019 and held it in 10 quarters. The position peaked at $3.23M in Q4 2019. 395 funds tracked by Wall St. Rank hold SRPT as of Q3 2023.

  • PEAK6 Investments reported no remaining Sarepta Therapeutics position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 5,094 Sarepta Therapeutics shares in Q3 2023, an estimated $576K.
  • PEAK6 Investments first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 10 quarters.
  • PEAK6 Investments's Sarepta Therapeutics position peaked at $3.23M in Q4 2019.
  • 395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.